ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Long-term debt (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $29.6B | +128.9% | −11.8% | 5.4% |
| Long-term debt (Q2 2026) | $29.6B |
|---|---|
| YoY | +128.9% |
| 5-year CAGR | −11.8% |
| 10-year CAGR | 5.4% |
Long-term debt
| Period | Long-term debt | YoY |
|---|---|---|
| 2025 | $9.9B | −21.6% |
| 2024 | $12.6B | −7.2% |
| 2023 | $13.6B | −6.4% |
| 2022 | $14.5B | −16.0% |
| 2021 | $17.3B | −6.6% |
| 2020 | $18.5B | +11.2% |
| 2019 | $16.7B | −13.9% |
| 2018 | $19.4B | −28.9% |
| 2017 | $27.2B | +31.6% |
| 2016 | $20.7B | +252.3% |
| 2015 | $5.9B | +73.0% |
| 2014 | $3.4B | +0.1% |
| 2013 | $3.4B | −81.3% |
| 2012 | $18.1B | +50.2% |
| 2011 | $12.0B | −3.9% |
| 2010 | $12.5B | +11.2% |
| 2009 | $11.3B | +29.3% |
| 2008 | $8.7B | −8.2% |
| 2007 | $9.5B | — |